Study answers questions about long-term survivorship following CAR T treatment
Axicabtagene ciloleucel, commonly known as axi-cel, is an innovative immunotherapy that uses modified T cells to target and destroy cancer cells. Approved for patients who have not responded to at least two prior lines of ...
Aug 5, 2024
0
0